Status:
COMPLETED
Clinical Insights Into Dextrose Phonophoresis on Mild to Moderate Acne Vulgaris
Lead Sponsor:
MTI University
Conditions:
Acne Vulgaris
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
Acne vulgaris is a common cutaneous inflammatory disorder of the pilosebaceous unit, which runs a chronic course. The condition commonly manifests with papules, pustules, or nodules primarily on the f...
Detailed Description
Dextrose phonophoresis emerges as a novel therapeutic modality in the management of mild to moderate acne vulgaris, an inflammatory skin condition that affects a significant portion of the adolescent ...
Eligibility Criteria
Inclusion
- Individuals aged 18 to 30 years.
- Clinically diagnosed with mild to moderate acne vulgaris.
- Willingness to comply with the study protocol and attend all treatment sessions.
- Medical Clearance: Participants must have medical clearance to participate in this study.
Exclusion
- Individuals with severe acne vulgaris or other dermatological conditions affecting the face.
- Current use of systemic acne medications or topical treatments other than the study intervention.
- Known allergy to magnesium or ultrasound gel.
- Pregnant or breastfeeding individuals.
- Severe Comorbidities: Individuals with severe cardiovascular, pulmonary, metabolic, or vascular diseases
- Medication Interference: Individuals using medications known to affect presence of acne.
- Acute Psychological Conditions: Participants with acute psychological conditions that may interfere with participation or assessments.
- Obese patient whose BMI ≥ 30.
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT07169890
Start Date
November 1 2025
End Date
December 1 2025
Last Update
December 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
faculty of physical therapy ,Cairo University
Cairo, Egypt, 11311